VIA
MRNA icon

Virtus Investment Advisers’s Moderna MRNA Stock Holding History

Virtus Investment Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
23,300
-5,356
-19% -$277K 0.38% 105
2026
Q1 		$1.46M Buy
28,656
+5,459
+24% +$255K 0.4% 122
2025
Q4 		$684K Buy
23,197
+6,949
+43% +$189K 0.19% 179
2025
Q3 		$420K Hold
16,248
– – 0.12% 223
2025
Q2 		$448K Buy
16,248
+7,863
+94% +$207K 0.15% 197
2025
Q1 		$238K Buy
+8,385
New +$298K 0.06% 254

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Virtus Investment Advisers's MRNA Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Moderna (MRNA) stake by 19% in Q2 2026, selling an estimated $277K and leaving 23,300 shares worth $1.63M. The position accounts for 0.38% of the portfolio, ranked #105.

Virtus Investment Advisers first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 781 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Virtus Investment Advisers held 23,300 shares of Moderna worth $1.63M as of Q2 2026.
  • Virtus Investment Advisers sold 5,356 Moderna shares in Q2 2026, an estimated $277K.
  • Moderna made up 0.38% of Virtus Investment Advisers's portfolio in Q2 2026, its #105 holding.
  • Virtus Investment Advisers first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 781 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.